Skip to content

Bruce Booth, Director at Kymera Therapeutics, sold KYMR on Jun 29, 2026

Data as of Oct 16

▼ SELL$101K907 shares at $111.20Bruce Booth DirectorKYMR Kymera Therapeutics, Inc.
Watch KYMR
Traded
Jun 29, 2026
Disclosed
Jun 30, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Bruce Booth, Director at Kymera Therapeutics, sold KYMR on Jun 29, 2026TRADEDDISCLOSED
KYMRSimilar stocks (XLV — its sector index fund), rebased to KYMR's price on the disclosure day
KYMR since disclosure
−8.6%
after the sale
Similar stocks (XLV) since disclosure
+11.4%
XLV — its sector index fund

Change in closing price from Jun 30, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLBruce Booth DirectorKYMR Kymera Therapeutics, Inc.$133Kdisclosed Jun 30 · filed 1 day after the trade
  2. ▼ SELLBruce Booth DirectorKYMR Kymera Therapeutics, Inc.$841Kdisclosed Jun 30 · filed 1 day after the trade
  3. ▼ SELLBruce Booth DirectorKYMR Kymera Therapeutics, Inc.$17.5Kdisclosed Jun 30 · filed 1 day after the trade
  4. ▼ SELLBruce Booth DirectorKYMR Kymera Therapeutics, Inc.$860Kdisclosed Jun 30 · filed 1 day after the trade
  5. ▼ SELLBruce Booth DirectorKYMR Kymera Therapeutics, Inc.$183Kdisclosed Jun 30 · filed 1 day after the trade
  6. ▼ SELLBruce Booth DirectorKYMR Kymera Therapeutics, Inc.$1.2Mdisclosed Jun 30 · filed 1 day after the trade
  7. ▼ SELLBruce Booth DirectorKYMR Kymera Therapeutics, Inc.$136Kdisclosed Jun 30 · filed 1 day after the trade

See every trade on KYMR →